SCHEMBL9010998

SCHEMBL9010998

O=C(O)Cc1cccc(C2(O)CCN(C(=O)c3ccco3)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.53
CYP3A4 P08684 10/20 0.53
CYP2D6 P10635 7/20 0.53
CHRM2 P08172 1/20 0.53
CYP1A2 P05177 7/20 0.51
USP2 O75604 10/20 0.51
CYP2C19 P33261 6/20 0.50
CYP2C9 P11712 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
HIF1A Q16665 3/20 0.49
MAPK1 P28482 2/20 0.49
HSD17B10 Q99714 2/20 0.49
HPGD P15428 1/20 0.49
TP53 P04637 1/20 0.48
TSHR P16473 3/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27346073 0.85 ALDH1A1 (0.64) ALDH1A1CYP3A4CYP2D6CHRM2CYP1A2
SCHEMBL7814086 0.84 ALDH1A1 (0.56) ALDH1A1CYP3A4CYP2D6CHRM2CYP1A2
SCHEMBL9011241 0.81 NOS2 (0.53) ALDH1A1SMN1; SMN2HTT
SCHEMBL9011281 0.80 NPC1 (0.56) ALDH1A1USP2HSD17B10HPGDTSHR
SCHEMBL7813466 0.78 CYP1A2 (0.48) ALDH1A1CYP3A4CYP2D6CHRM2CYP1A2
SCHEMBL9011197 0.78 ALDH1A1 (0.65) ALDH1A1CYP3A4CHRM2CYP2C19CYP2C9
SCHEMBL9011030 0.77 USP2 (0.71) ALDH1A1CYP3A4CYP2D6CYP1A2USP2
SCHEMBL9011044 0.77 PKLR (0.47) ALDH1A1CYP3A4CHRM2CYP1A2CYP2C19
SCHEMBL3408619 0.77 AKR1B1 (0.46) ALDH1A1CYP1A2CYP2C19HIF1AHSD17B10
SCHEMBL9011012 0.75 RAB9A (0.62) ALDH1A1SMN1; SMN2MAPK1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1035178-C Arylamide derivatives SS PHARMACEUTICAL CO (JP) 1997-06-18 CN disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed